Also from this source


You just read:

Immune Therapeutics, Inc. Announces Exclusive Agreement For Sale Of Lodonal In Kenya Valued At Over $31 Million

News provided by

Immune Therapeutics, Inc.

Sep 06, 2017, 08:05 ET